HELIUM EVOLUTION INC (HEVI.CA) Stock Fundamental Analysis

Canada • TSX Venture Exchange • TSX-V:HEVI • CA42328K1021

0.135 CAD
+0.01 (+3.85%)
Last: Feb 9, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall HEVI gets a fundamental rating of 1 out of 10. We evaluated HEVI against 25 industry peers in the Chemicals industry. HEVI has a bad profitability rating. Also its financial health evaluation is rather negative. HEVI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • HEVI had negative earnings in the past year.
  • HEVI had a negative operating cash flow in the past year.
HEVI.CA Yearly Net Income VS EBIT VS OCF VS FCFHEVI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • The Return On Assets of HEVI (-15.25%) is comparable to the rest of the industry.
  • The Return On Equity of HEVI (-28.72%) is worse than 60.00% of its industry peers.
Industry RankSector Rank
ROA -15.25%
ROE -28.72%
ROIC N/A
ROA(3y)-31.68%
ROA(5y)N/A
ROE(3y)-33.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEVI.CA Yearly ROA, ROE, ROICHEVI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HEVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HEVI.CA Yearly Profit, Operating, Gross MarginsHEVI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • HEVI has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, HEVI has an improved debt to assets ratio.
HEVI.CA Yearly Shares OutstandingHEVI.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
HEVI.CA Yearly Total Debt VS Total AssetsHEVI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • HEVI has an Altman-Z score of -0.24. This is a bad value and indicates that HEVI is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.24, HEVI perfoms like the industry average, outperforming 48.00% of the companies in the same industry.
  • HEVI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • HEVI's Debt to Equity ratio of 0.00 is amongst the best of the industry. HEVI outperforms 92.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.24
ROIC/WACCN/A
WACCN/A
HEVI.CA Yearly LT Debt VS Equity VS FCFHEVI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • HEVI has a Current Ratio of 0.90. This is a bad value and indicates that HEVI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HEVI's Current ratio of 0.90 is on the low side compared to the rest of the industry. HEVI is outperformed by 60.00% of its industry peers.
  • A Quick Ratio of 0.90 indicates that HEVI may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.90, HEVI is in line with its industry, outperforming 44.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.9
HEVI.CA Yearly Current Assets VS Current LiabilitesHEVI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • HEVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.09%.
EPS 1Y (TTM)-22.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-652.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HEVI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HEVI.CA Price Earnings VS Forward Price EarningsHEVI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HEVI.CA Per share dataHEVI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for HEVI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HELIUM EVOLUTION INC

TSX-V:HEVI (2/9/2026, 7:00:00 PM)

0.135

+0.01 (+3.85%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-25
Earnings (Next)04-20
Inst Owners6.28%
Inst Owner ChangeN/A
Ins Owners10.82%
Ins Owner ChangeN/A
Market Cap22.01M
Revenue(TTM)N/A
Net Income(TTM)-3.35M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.89
P/tB 1.89
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.25%
ROE -28.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.68%
ROA(5y)N/A
ROE(3y)-33.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41261.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.9
Altman-Z -0.24
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9063.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-652.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-255.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-219.15%
OCF growth 3YN/A
OCF growth 5YN/A

HELIUM EVOLUTION INC / HEVI.CA FAQ

Can you provide the ChartMill fundamental rating for HELIUM EVOLUTION INC?

ChartMill assigns a fundamental rating of 1 / 10 to HEVI.CA.


What is the valuation status of HELIUM EVOLUTION INC (HEVI.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to HELIUM EVOLUTION INC (HEVI.CA). This can be considered as Overvalued.


Can you provide the profitability details for HELIUM EVOLUTION INC?

HELIUM EVOLUTION INC (HEVI.CA) has a profitability rating of 0 / 10.


How financially healthy is HELIUM EVOLUTION INC?

The financial health rating of HELIUM EVOLUTION INC (HEVI.CA) is 2 / 10.